Selective p38 activation in human non-small cell lung cancer.
暂无分享,去创建一个
[1] S. Deventer,et al. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps , 2001, Oncogene.
[2] T. Patel,et al. Involvement of p38 mitogen‐activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line , 2001, Hepatology.
[3] B. Evers,et al. Downregulation of mitogen-activated protein kinases in human colon cancers. , 2000, Anticancer research.
[4] T. Lee,et al. Molecular and genetic aspects of lung cancer. , 2000, American journal of respiratory and critical care medicine.
[5] J. Bonventre,et al. Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells. , 2000, Cancer Research.
[6] W. Lang,et al. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. , 2000, Cancer Research.
[7] D. Spandidos,et al. Activation of the ras genes in malignant and premalignant colorectal tumors. , 1998, Oncology reports.
[8] E. Goldsmith,et al. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation , 1998, Current Biology.
[9] Channing J Der,et al. Increasing complexity of Ras signaling , 1998, Oncogene.
[10] Y. Bang,et al. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. , 1998, Biochemical and biophysical research communications.
[11] C. Der,et al. Increasing Complexity of the Ras Signaling Pathway* , 1998, The Journal of Biological Chemistry.
[12] M. Wigler,et al. Signaling pathways in Ras-mediated tumorigenicity and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Brenner,et al. Analysis of Signaling Protein Kinases in Human Colon or Colorectal Carcinomas , 1998, Digestive Diseases and Sciences.
[14] M. Cobb,et al. Identification of Substrates and Regulators of the Mitogen-activated Protein Kinase ERK5 Using Chimeric Protein Kinases* , 1998, The Journal of Biological Chemistry.
[15] J. Gutkind. The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.
[16] D. Brenner,et al. In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia. , 1997, Gastroenterology.
[17] G. Nuovo,et al. Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.
[18] H. Greulich,et al. Mek1 Phosphorylation Site Mutants Activate Raf-1 in NIH 3T3 Cells* , 1996, The Journal of Biological Chemistry.
[19] M. Loda,et al. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. , 1996, The American journal of pathology.
[20] M. Cobb,et al. ERK3 Is a Constitutively Nuclear Protein Kinase (*) , 1996, The Journal of Biological Chemistry.
[21] O Yoshida,et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.
[22] M. J. Atten,et al. Decreased MAP kinase activity in human gastric adenocarcinoma. , 1995, Biochemical and biophysical research communications.
[23] W. Rom,et al. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. , 1995, Journal of the National Cancer Institute.
[24] M. Karin. The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[25] W. Rom,et al. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. , 1995, Cancer research.
[26] N. Ahn,et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. , 1994, Science.
[27] C. Marshall,et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.
[28] A. Brunet,et al. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.
[29] S. Pelech,et al. MAP kinases: charting the regulatory pathways. , 1992, Science.
[30] T. Pechacek,et al. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.
[31] Daniel S. Miller,et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.
[32] N. Ahn,et al. Signal transduction through MAP kinase cascades. , 1998, Advances in cancer research.
[33] M. J. Atten,et al. MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. , 1996, Anticancer research.
[34] A. Chambers,et al. Ras-responsive genes and tumor metastasis. , 1993, Critical reviews in oncogenesis.
[35] F. McCormick,et al. Regulators and effectors of ras proteins. , 1991, Annual review of cell biology.